| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-06 | 2009-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,210 | Added More | 1,200 | 17.11 % | $180,620 | $192,525 | $11,905 | 6.59 % | $1,740 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2009-08-10 | 2009-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,010 | Sold Some | -1,290 | -15.54 % | $111,810 | $164,385 | $52,575 | 47.02 % | $-9,675 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,300 | Added More | 360 | 4.53 % | $98,355 | $194,635 | $96,280 | 97.89 % | $4,176 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2009-02-13 | 2008-12-31 | 13F-HR/A | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,940 | Added More | 130 | 1.66 % | $104,570 | $186,193 | $81,623 | 78.05 % | $1,336 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2008-11-14 | 2008-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,810 | Sold Some | -85 | -1.07 % | $85,754 | $183,145 | $97,391 | 113.57 % | $-1,060 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2008-08-13 | 2008-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,895 | Sold Some | -203,090 | -96.25 % | $120,478 | $185,138 | $64,660 | 53.66 % | $-1,663,307 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2008-05-15 | 2008-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 210,985 | Sold Some | -27,015 | -11.35 % | $3,662,700 | $4,947,598 | $1,284,899 | 35.08 % | $-164,521 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2008-02-15 | 2007-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 238,000 | Added More | 76,300 | 47.18 % | $4,574,360 | $5,581,100 | $1,006,740 | 22.00 % | $322,749 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2007-12-14 | 2007-09-30 | 13F-HR/A | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 161,700 | Added More | 154,600 | 2177.46 % | $3,423,189 | $3,791,865 | $368,676 | 10.76 % | $352,488 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2007-08-02 | 2007-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,100 | Sold Some | -14,800 | -67.57 % | $163,229 | $166,495 | $3,266 | 2.00 % | $-6,808 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2007-05-24 | 2007-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 21,900 | Added More | 13,000 | 146.06 % | $629,187 | $513,555 | $-115,632 | -18.37 % | $-68,640 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2007-02-14 | 2006-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,900 | No Change | 0 | 0 % | $223,924 | $208,705 | $-15,219 | -6.79 % | $0 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2006-11-13 | 2006-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,900 | No Change | 0 | 0 % | $163,493 | $208,705 | $45,212 | 27.65 % | $0 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2006-08-11 | 2006-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,900 | Added More | 1,300 | 17.10 % | $144,714 | $208,705 | $63,991 | 44.21 % | $9,347 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2006-05-12 | 2006-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,600 | Added More | 100 | 1.33 % | $170,240 | $178,220 | $7,980 | 4.68 % | $105 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2006-02-13 | 2005-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,500 | Sold Some | -1,200 | -13.79 % | $251,400 | $175,875 | $-75,525 | -30.04 % | $12,084 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2005-11-07 | 2005-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,700 | Added More | 500 | 6.09 % | $223,068 | $204,015 | $-19,053 | -8.54 % | $-1,095 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2005-08-11 | 2005-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,200 | Added More | 100 | 1.23 % | $202,294 | $192,290 | $-10,004 | -4.94 % | $-122 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2005-05-12 | 2005-03-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 8,100 | Added More | 400 | 5.19 % | $248,427 | $189,945 | $-58,482 | -23.54 % | $-2,888 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2005-02-16 | 2004-12-31 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,700 | Added More | 100 | 1.31 % | $290,290 | $180,565 | $-109,725 | -37.79 % | $-1,425 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2004-11-04 | 2004-09-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,600 | Added More | 100 | 1.33 % | $272,916 | $178,220 | $-94,696 | -34.69 % | $-1,246 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
| 2004-07-26 | 2004-06-30 | 13F-HR | Par Pharmaceutical Cos Inc | PRX | US | Medical-Generic Drugs | 7,500 | New Holding | 7,500 | 100 % | $244,425 | $175,875 | $-68,550 | -28.04 % | $-68,550 | | | | | | History of Hartford Investment Management Co Ownership Of Par Pharmaceutical Cos Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |